Sign Up
OverviewAPI
Orca Bio presents promising data at ASH Annual Meeting for its investigational cell therapies, Orca-T and Orca-Q, demonstrating potential for expanding treatment to additional patient groups. FDA approvals for gene therapies for sickle cell disease at ASH. CAR-T cell therapy shows promise in treating autoimmune diseases like lupus. Study highlights challenges in caring for people with sickle cell disease.

Ask a question